bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.04.20.537661

Antimicrobial Susceptibility Profile of Neisseria gonorrhoeae from Patients Attending a Medical Laboratory, Institut Pasteur de Madagascar between 2014-2020: Phenotypic and Genomic characterization in a Subset of Neisseria gonorrhoeae Isolates.

Abstract

2The antimicrobial resistance of Neisseria gonorrhoea to all classes of current available antibiotics is a global concern. National surveillance programmes monitoring the susceptibility profiles of Neisseria gonorrhoeae hardly exist in resource constraint settings. Therefore, little is known about the antimicrobial susceptibility profile and associated genetic resistance mechanisms of N. gonorrhoeae in Madagascar. We report susceptibility data of N. gonorrhoeae isolates obtained by the medical laboratory of the Institut Pasteur de Madagascar, from 2014 -2020. In addition, we present data on the antimicrobial resistance mechanisms and antimicrobial resistance profile of a subset of isolates (N=46), including all isolates available of 2020. Over the study period, ceftriaxone resistant isolates exceeding the threshold of 5% in 2017 and 2020, were reported. Of the subset of re-tested isolates, all were found susceptible to ceftriaxone, azithromycin, and spectinomycin. Conversely, all isolates were resistant to ciprofloxacin and the majority was also resistant to penicillin and tetracycline. None of the isolates carried the mosaic penA gene and chromosomal mutations associated to the antibiotic resistance in gyrA, parC, penA, ponA, porB and mtrR genes were detected. The high rate of resistance to Penicillin and Tetracycline is explained by the presence of {beta}-lactamase blaTEM and tetM genes, respectively, a plasmid mediated resistance. We found a high number of circulating multilocus sequence types. Almost half of them were new types, and one of them was among the four most predominant sequence types. Our report provides a detailed dataset obtained through phenotypic and genotypic methods which will serve as baseline for future surveillance of N. gonorrhoeae in our setting, and Madagascar. 1.5 RepositoriesThis Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under the Accession BioProject PRJNA929018. 3 Impact statementNeisseria gonorrhoeae is becoming increasingly resistant to all classes of antibiotics available for infections treatment. Resource constraint settings encounter difficulties in implementing surveillance of the antimicrobial susceptibility of N. gonorrhoeae. We report here antimicrobial susceptibility results from gonorrhoea among patients consulting a medical laboratory in Antananarivo, Madagascar in 2014-2020. We used whole-genome sequencing to identify resistance mechanisms in a subset of isolates including all viable isolates of 2020. We report multilocus sequence types and discuss phenotypes and genotypes according to the phylogenetic analysis of the isolates. The susceptibility results are the first in a decade to be reported. We set the baseline to study further the evolution and transmission of N. gonorrhoeae resistance mechanisms and genotypes in general. Our report will enable improving surveillance of Neisseria gonorrhoeae in Madagascar and Africa. Overall, it will contribute to the global, regional, and national surveillance of N. gonorrhoeae. In addition, it may set a benchmark for implementation in other settings facing barriers implementing phenotypic resistance surveillance of N. gonorrhoeae. 4 Data summaryThe source code of the Tormes pipeline used in this study is also available on Github: https://github.com/nmquijada/tormes. The SRA sequences have been deposited in the NCBI SRA database under accession numbers SRR23260223 and SRR23260193. The genome assemblies can be accessed using the accession numbers: SAMN32949360 - SAMN32949405. The MLST genes of all isolates can be accessed through this link: https://doi.org/10.5281/zenodo.7581537 The Perl scripts used for a quality filtering of the assemblies which is to remove small contigs can be accessed through the following link: https://github.com/Alainnoah/Remove-Small-Contigs-Draft-Assemblies. Genomic analysis with metadata in Pathogenwatch could be accessed with this link: https://pathogen.watch/collection/f7t4wjtjlybh-mdgwhofa A visualization of genomic epidemiology of our isolates with Microreact can be accessed with this link: https://microreact.org/project/7FADQYwhm5h1zJyJTynM6R-unnamed-project A supplementary material in an Excel sheet summarizing the lists of plasmids used for alignment (Table S1), the statistics of the sequences (Table S2), and the minimum inhibitory concentration values of N. gonorrhoeae isolates and their antimicrobial resistance genetic mechanisms (Table S3) is available through this link: https://doi.org/10.6084/m9.figshare.21973511

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Rafetrarivony, L., Rabenandrasana, M. A. N., Ratsima Hariniana, E., Randrianirina, F., Smith, A. M., Crucitti, T.. 2023-04-20. Antimicrobial Susceptibility Profile of Neisseria gonorrhoeae from Patients Attending a Medical Laboratory, Institut Pasteur de Madagascar between 2014-2020: Phenotypic and Genomic characterization in a Subset of Neisseria gonorrhoeae Isolates.. https://doi.org/10.1101/2023.04.20.537661

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗